Qualitative and quantitative analysis of THC, 11-hydroxy-THC and 11-nor-9-carboxy-THC in whole blood by ultra-performance liquid chromatography/tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 18, 2011, Pages 2603-2610

  Simões, Susana Sadler ^a   Ajenjo, Antonio Castañera ^a   Dias, Mário João ^a  

^a INSTITUTO NACIONAL DE MEDICINA LEGAL E CIÊNCIAS FORENSES   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION;

ANALYTICAL METHOD; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; OH -; QUALITATIVE AND QUANTITATIVE ANALYSIS; RELATIVE RETENTION TIME; SIMULTANEOUS DETERMINATIONS; SOLID-PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WHOLE BLOOD;

POSITIVE IONS;

EID: 80052555187     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5165     Document Type: Article

References (30)

1. M. A. Huestis. Cannabis (Marijuana) - Effects on human behaviour and performance. Forensic Sci. Rev. 2002, 14, 15.
2. F. Musshoff, B. Madea. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther. Drug Monit. 2006, 28, 155.
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug use, impaired driving and traffic accidents. Insights Series No 8. Lisbon, November 2008. Available: http://www.emcdda.europa.eu/publications/insights/ driving.
4. 9tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction 2009, 104, 2041.
5. M. A. Huestis, J. E. Henningfield, E. J. Cone. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking Marijuana. J. Anal. Toxicol. 1992, 16, 276.
6. A. P. Mason, A. J. McBay. Cannabis: pharmacology and interpretation of effects. J. Forensic Sci. 1985, 30, 615.
7. H. Gjerde, G. Kinn. Impairment in drivers due to cannabis in combination with other drugs. Forensic Sci. Int. 1991, 50, 57.
8. A. P. Mason, A. J. McBay. Ethanol, Marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981. J. Forensic Sci. 1984, 29, 987.
9. H. Z. Khiabani, J. G. Bramness, A. Bjorneboe, J. Morland. Relationship between THC concentrationinblood and impairment in apprehended drivers. Traff. Inj. Prev. 2006, 7, 111.
10. S. J. Heishman, M. A. Huestis, J. E. Henningfield, E. J. Cone. Acute and residual effects of Marijuana: profiles of plasma THC levels, phisiological, sujective and performance measures. Pharmacol. Biochem. Behav. 1990, 37, 561.
11. P. Mura, P. Kintz, B. Ludes, J. M. Gaulier, P. Marquet, S. Martin-Dupont, F. Vincent, A. Kaddour, J. P. Goulle, J. Nouveau, M. Mouslma, S. Tilhet-Coartet, O. Pourrat. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci. Int. 2003, 133, 79.
12. M. A. Peat. Distribution of delta-9-tetrahydrocannabinol and its metabolites, in Advances in Analytical Toxicology II, (Ed: R. C. Baselt), Year Book Medical Publishers, Chicago, 1989.
13. 9- tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J. Anal. Toxicol. 2009, 33, 469.
14. 9-tetrahydrocannabinol in urine and blood using gas chromatography-mass spectrometry (GC-MS). Methods Mol. Biol. 2010, 603, 137.
15. 9tetrahydrocannabinol-9-carboxylic acid in urine using disposable pipette extraction with confirmation and quantification by gas chromatography-mass spectrometry. J. Anal. Toxicol. 2008, 32, 659.
16. A. Thomas, C. Widmer, G. Hopfgartner, C. Staub. Fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry for forensic analysis of cannabinoids in whole blood. J. Pharm. Biomed. Anal. 2007, 45, 495.
17. 9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry. J. Anal. Toxicol. 2006, 30, 262.
18. M. H. Chu, O. H. Drummer. Determination of δ9-THC in whole blood using gas chromatography-mass spectrometry. J. Anal. Toxicol. 2002, 26, 575.
19. C. Coulter, E. Miller, K. Crompton, C. Moore. Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2008, 32, 653.
20. S. König, B. Aebi, S. Lanz, M. Gasser, W. Weinmann. On-line SPE LC-MS/MS for the quantification of δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 2011, 400, 9.
21. A. A. Elian, J. Hackett. Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid-phase extraction sorbent and fast liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2009, 33, 461.
22. E. Jagerdeo, J. E. Schaff, M. A. Montgomery, M. A. LeBeau. A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood. Rapid Commun. Mass Spectrom. 2009, 23, 2697.
23. M. R. Fernandez, G. De Boeck, M. Wood, M. Lopez-Rivadulla, N. Samyn. Simultaneous analysis of THC and its metabolites in blood using liquid chromatographytandem mass spectrometry. J. Chromatogr. B 2008, 875, 465.
24. C. Jamey, E. Szware, A. Tracqui, B. Ludes. Determination of cannabinoids in whole blood by UPLC-MS-MS. J. Anal. Toxicol. 2008, 32, 349.
25. A. M. Almeida, M. M. Castel-Branco, A. C. Falcão. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J. Chromatogr. B 2002, 774, 215.
26. 9- tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 2004, 39, 526.
27. S. B. Grauwiller, A. Scholer, J. Drewe. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J. Chromatogr. B 2007, 850, 515.
28. WADA - World Anti-Doping Agency. International Standard for Laboratories. Identification criteria for qualitative assays TD2010IDCR. Available: http://www.wada-ama.org/en/Anti-Doping-Community/Anti-Doping-Laboratories/ Technical-Documents/.
29. L. J. Farrell, S. Kerrigan, B. K. Logan. Recommendations of toxicological investigation of drug impaired driving. J. Forensic Sci. 2007, 52, 1214.
30. W. R. Nickel, J. De Gier. Driving Under the Influence of Alcohol and Drugs: A Survey on Zero Tolerance, Saliva Testing and Sanctions, Research Project for the Ministry of Justice and the Ministry of Transport, Public Works and Water Management of The Netherlands. Unpublished report, October, 2009.